Table 2.
Patient characteristics before and after lockdown.
| NAFLD SC Group (n = 28) |
p-valueb | NAFLD Intervention Group (n = 27) |
p-valueb | |
|---|---|---|---|---|
| Weight (kg) | ||||
| Before lockdown | 79.1 ± 10.7 | <0.001 | 77.0 ± 11.7 | 0.099 |
| After lockdown | 82.2 ± 11.4 | 77.6 ± 12.3 | ||
| BMI (kg/m2) | ||||
| Before lockdown | 28.3 ± 4.4 | <0.001 | 26.8 ± 4.4 | 0.094 |
| After lockdown | 29.5 ± 4.7 | 27.0 ± 4.6 | ||
| BMI Obesity category (%) | ||||
| Before lockdown | 30.8 | >0.05 | 24 | >0.05 |
| After lockdown | 34.6 | 28 | ||
| Glycemiaa | ||||
| Before lockdown | 95.7 ± 15.4 | 0.023 | 94.6 ± 13.7 | >0.05 |
| After lockdown | 110.2 ± 31.0 | 97.6 ± 10.4 | ||
| Triglyceridesa | ||||
| Before lockdown | 174.8 ± 56.5 | >0.05 | 148.9 ± 58.5 | >0.05 |
| After lockdown | 201.0 ± 83.2 | 126.2 ± 44.4 | ||
| Total Cholesterola | ||||
| Before lockdown | 220.6 ± 49.8 | >0.05 | 216.6 ± 41.3 | >0.05 |
| After lockdown | 214.8 ± 63.6 | 214.6 ± 45.7 | ||
| HDL cholesterola | ||||
| Before lockdown | 52.9 ± 16.3 | >0.05 | 52.2 ± 11.8 | >0.05 |
| After lockdown | 50.3 ± 16.9 | 53.4 ± 9.4 | ||
| FIB-4 low probability of fibrosisa (%) | ||||
| Before lockdown | 80.8 | >0.05 | 100 | 0.038 |
| After lockdown | 91.7 | 69.2 | ||
Values presented as % of patients or mean ± SD; BMI: Body Massa Index; AST: Aspartate transaminase, ALT: Alanine aminotransferase; NAFDL: non-alcoholic fatty liver disease; HIV: human immunodeficiency virus.
a
Available from 12 patients in the STD group and 13 patients in the intervention group.
b
Reported comparison between before and after lockdown.